Skip to main content
Top
Published in: European Journal of Medical Research 6/2009

01-12-2009 | Research

BCL2-938C > A and CALCA-1786T > C polymorphisms in aseptic loosened total hip arthroplasty

Authors: C Wedemeyer, MD Kauther, S Hanenkamp, H Nückel, M Bau, W Siffert, HS Bachmann

Published in: European Journal of Medical Research | Issue 6/2009

Login to get access

Abstract

The search for influencing factors and new pathways in aseptic loosening of arthroplasties is a major focus of recent studies. Analyses of polymorphisms of genes revealed a correlation between a specific allele variant and aseptic loosening. The BCL2 gene encoding Bcl-2 with its BCL2 -938C > A polymorphism is a crucial factor of cell cycle control and cell survival. The CALCA -1786T > C polymorphism belongs to the CALCA gene encoding alpha-Calcitonin Gene Related Peptide (CGRP) and Calcitonin. Both proteins are important in bone metabolism and capable to influence the process of aseptic loosening. To date, no studies are reported for aseptic loosening with these two single nucleotide polymorphisms (SNPs). In a retrospective study we determined the distribution of the BCL2-938C > A and the CALCA-1786T > C polymorphisms in 87 subjects with aseptic loosened hip arthroplasties using RFLP and pyrosequencing analysis. Genotype distribution with prognosis of the hip arthroplasty showed neither an association with clinical characteristics of the patients nor the implantation technique. We were unable to detect any influence of these polymorphisms on time to aseptic loosening.
Literature
go back to reference Amara SG, Jonas V, et al.: "Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products.". Nature 1982,298(5871):240–4. 10.1038/298240a0PubMedCrossRef Amara SG, Jonas V, et al.: "Alternative RNA processing in calcitonin gene expression generates mRNAs encoding different polypeptide products.". Nature 1982,298(5871):240–4. 10.1038/298240a0PubMedCrossRef
go back to reference Bachmann HS, Otterbach F, et al.: "The AA genotype of the regulatory BCL2 promoter polymorphism (938C > A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.". Clin Cancer Res 2007,13(19):5790–7. 10.1158/1078-0432.CCR-06-2673PubMedCrossRef Bachmann HS, Otterbach F, et al.: "The AA genotype of the regulatory BCL2 promoter polymorphism (938C > A) is associated with a favorable outcome in lymph node negative invasive breast cancer patients.". Clin Cancer Res 2007,13(19):5790–7. 10.1158/1078-0432.CCR-06-2673PubMedCrossRef
go back to reference Berry DJ, Harmsen WS, et al.: "Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: factors affecting survivorship of acetabular and femoral components.". J Bone Joint Surg Am 2002,84-A(2):171–7.PubMed Berry DJ, Harmsen WS, et al.: "Twenty-five-year survivorship of two thousand consecutive primary Charnley total hip replacements: factors affecting survivorship of acetabular and femoral components.". J Bone Joint Surg Am 2002,84-A(2):171–7.PubMed
go back to reference Bredow S, Juri DE, et al.: "Identification of a novel Bcl-2 promoter region that counteracts in a p53-dependent manner the inhibitory P2 region.". Gene 2007,404(1–2):110–6. 10.1016/j.gene.2007.09.005PubMedCentralPubMedCrossRef Bredow S, Juri DE, et al.: "Identification of a novel Bcl-2 promoter region that counteracts in a p53-dependent manner the inhibitory P2 region.". Gene 2007,404(1–2):110–6. 10.1016/j.gene.2007.09.005PubMedCentralPubMedCrossRef
go back to reference Buervenich S, Xiang F, et al.: "Identification of four novel polymorphisms in the calcitonin/alpha-CGRP ( CALCA ) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression.". Hum Mutat 2001,17(5):435–6. 10.1002/humu.1126PubMedCrossRef Buervenich S, Xiang F, et al.: "Identification of four novel polymorphisms in the calcitonin/alpha-CGRP ( CALCA ) gene and an investigation of their possible associations with Parkinson disease, schizophrenia, and manic depression.". Hum Mutat 2001,17(5):435–6. 10.1002/humu.1126PubMedCrossRef
go back to reference Chao DT, Korsmeyer SJ: "BCL-2 family: regulators of cell death.". Annu Rev Immunol 1998, 16: 395–419. 10.1146/annurev.immunol.16.1.395PubMedCrossRef Chao DT, Korsmeyer SJ: "BCL-2 family: regulators of cell death.". Annu Rev Immunol 1998, 16: 395–419. 10.1146/annurev.immunol.16.1.395PubMedCrossRef
go back to reference Chen K, Hu Z, et al.: "Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.". Carcinogenesis 2007,28(9):2008–12. 10.1093/carcin/bgm172PubMedCrossRef Chen K, Hu Z, et al.: "Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.". Carcinogenesis 2007,28(9):2008–12. 10.1093/carcin/bgm172PubMedCrossRef
go back to reference Cory S, Adams JM: "The Bcl2 family: regulators of the cellular life-or-death switch.". Nat Rev Cancer 2002,2(9):647–56. 10.1038/nrc883PubMedCrossRef Cory S, Adams JM: "The Bcl2 family: regulators of the cellular life-or-death switch.". Nat Rev Cancer 2002,2(9):647–56. 10.1038/nrc883PubMedCrossRef
go back to reference Drees P, Eckardt A, et al.: "Mechanisms of disease: Molecular insights into aseptic loosening of orthopedic implants.". Nat Clin Pract Rheumatol 2007,3(3):165–71. 10.1038/ncprheum0428PubMedCrossRef Drees P, Eckardt A, et al.: "Mechanisms of disease: Molecular insights into aseptic loosening of orthopedic implants.". Nat Clin Pract Rheumatol 2007,3(3):165–71. 10.1038/ncprheum0428PubMedCrossRef
go back to reference Flugsrud GB, Nordsletten L, et al.: "The effect of middle-age body weight and physical activity on the risk of early revision hip arthroplasty: a cohort study of 1,535 individuals.". Acta Orthop 2007,78(1):99–107. 10.1080/17453670610013493PubMedCrossRef Flugsrud GB, Nordsletten L, et al.: "The effect of middle-age body weight and physical activity on the risk of early revision hip arthroplasty: a cohort study of 1,535 individuals.". Acta Orthop 2007,78(1):99–107. 10.1080/17453670610013493PubMedCrossRef
go back to reference Goodman MT, Ferrell R, et al.: "Calcitonin gene polymorphism CALCA -624 (T/C) and ovarian cancer.". Environ Mol Mutagen 2005,46(1):53–8. 10.1002/em.20134PubMedCrossRef Goodman MT, Ferrell R, et al.: "Calcitonin gene polymorphism CALCA -624 (T/C) and ovarian cancer.". Environ Mol Mutagen 2005,46(1):53–8. 10.1002/em.20134PubMedCrossRef
go back to reference Hink RL, Hokanson JE, et al.: "Investigation of DUSP8 and CALCA in alcohol dependence.". Addict Biol 2003,8(3):305–12. 10.1080/13556210310001602211PubMedCrossRef Hink RL, Hokanson JE, et al.: "Investigation of DUSP8 and CALCA in alcohol dependence.". Addict Biol 2003,8(3):305–12. 10.1080/13556210310001602211PubMedCrossRef
go back to reference Huebner AK, Schinke T, et al.: "Calcitonin deficiency in mice progressively results in high bone turnover.". J Bone Miner Res 2006,21(12):1924–34. 10.1359/jbmr.060820PubMedCrossRef Huebner AK, Schinke T, et al.: "Calcitonin deficiency in mice progressively results in high bone turnover.". J Bone Miner Res 2006,21(12):1924–34. 10.1359/jbmr.060820PubMedCrossRef
go back to reference Irie K, Hara-Irie F, et al.: "Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling.". Microsc Res Tech 2002,58(2):85–90. 10.1002/jemt.10122PubMedCrossRef Irie K, Hara-Irie F, et al.: "Calcitonin gene-related peptide (CGRP)-containing nerve fibers in bone tissue and their involvement in bone remodeling.". Microsc Res Tech 2002,58(2):85–90. 10.1002/jemt.10122PubMedCrossRef
go back to reference Jacobs JW, Goodman RH, et al.: "Calcitonin messenger RNA encodes multiple polypeptides in a single precursor.". Science 1981,213(4506):457–9. 10.1126/science.6264603PubMedCrossRef Jacobs JW, Goodman RH, et al.: "Calcitonin messenger RNA encodes multiple polypeptides in a single precursor.". Science 1981,213(4506):457–9. 10.1126/science.6264603PubMedCrossRef
go back to reference Kroemer G: "The proto-oncogene Bcl-2 and its role in regulating apoptosis.". Nat Med 1997,3(6):614–20. 10.1038/nm0697-614PubMedCrossRef Kroemer G: "The proto-oncogene Bcl-2 and its role in regulating apoptosis.". Nat Med 1997,3(6):614–20. 10.1038/nm0697-614PubMedCrossRef
go back to reference Landgraeber S, Toetsch M, et al.: "Over-expression of p53/BAK in aseptic loosening after total hip replacement.". Biomaterials 2006,27(15):3010–20. 10.1016/j.biomaterials.2006.01.006PubMedCrossRef Landgraeber S, Toetsch M, et al.: "Over-expression of p53/BAK in aseptic loosening after total hip replacement.". Biomaterials 2006,27(15):3010–20. 10.1016/j.biomaterials.2006.01.006PubMedCrossRef
go back to reference Landgraeber S, von Knoch M, et al.: "Extrinsic and intrinsic pathways of apoptosis in aseptic loosening after total hip replacement.". Biomaterials 2008,29(24–25):3444–3450. 10.1016/j.biomaterials.2008.04.044PubMedCrossRef Landgraeber S, von Knoch M, et al.: "Extrinsic and intrinsic pathways of apoptosis in aseptic loosening after total hip replacement.". Biomaterials 2008,29(24–25):3444–3450. 10.1016/j.biomaterials.2008.04.044PubMedCrossRef
go back to reference Morita A, Nakayama T, et al.: "Association between the calcitonin-related peptide alpha ( CALCA ) gene and essential hypertension in Japanese subjects.". Am J Hypertens 2007,20(5):527–32. 10.1016/j.amjhyper.2006.06.008PubMedCrossRef Morita A, Nakayama T, et al.: "Association between the calcitonin-related peptide alpha ( CALCA ) gene and essential hypertension in Japanese subjects.". Am J Hypertens 2007,20(5):527–32. 10.1016/j.amjhyper.2006.06.008PubMedCrossRef
go back to reference Nuckel H, Frey UH, et al.: "Association of a novel regulatory polymorphism (-938C > A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.". Blood 2007,109(1):290–7. 10.1182/blood-2006-03-007567PubMedCrossRef Nuckel H, Frey UH, et al.: "Association of a novel regulatory polymorphism (-938C > A) in the BCL2 gene promoter with disease progression and survival in chronic lymphocytic leukemia.". Blood 2007,109(1):290–7. 10.1182/blood-2006-03-007567PubMedCrossRef
go back to reference Paprosky WG, Bradford MS, et al.: "Classification of bone defects in failed prostheses.". Chir Organi Mov 1994,79(4):285–91.PubMed Paprosky WG, Bradford MS, et al.: "Classification of bone defects in failed prostheses.". Chir Organi Mov 1994,79(4):285–91.PubMed
go back to reference Park BL, Kim LH, et al.: "Identification of variants in cyclin D1 (CCND1) and B-Cell CLL/lymphoma 2( BCL2 ).". J Hum Genet 2004,49(8):449–54.PubMedCrossRef Park BL, Kim LH, et al.: "Identification of variants in cyclin D1 (CCND1) and B-Cell CLL/lymphoma 2( BCL2 ).". J Hum Genet 2004,49(8):449–54.PubMedCrossRef
go back to reference Rosenfeld MG, Mermod JJ, et al.: "Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing.". Nature 1983,304(5922):129–35. 10.1038/304129a0PubMedCrossRef Rosenfeld MG, Mermod JJ, et al.: "Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing.". Nature 1983,304(5922):129–35. 10.1038/304129a0PubMedCrossRef
go back to reference Seto M, Jaeger U, et al.: "Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma.". Embo J 1988,7(1):123–31.PubMedCentralPubMed Seto M, Jaeger U, et al.: "Alternative promoters and exons, somatic mutation and deregulation of the Bcl-2-Ig fusion gene in lymphoma.". Embo J 1988,7(1):123–31.PubMedCentralPubMed
go back to reference Shipman R, Schraml P, et al.: "Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma.". Hum Genet 1993,91(5):455–8.PubMedCrossRef Shipman R, Schraml P, et al.: "Loss of heterozygosity on chromosome 11p13 in primary bladder carcinoma.". Hum Genet 1993,91(5):455–8.PubMedCrossRef
go back to reference Silva MJ, Sandell LJ: "What's new in orthopaedic research.". J Bone Joint Surg Am 2002,84-A(8):1490–6.PubMed Silva MJ, Sandell LJ: "What's new in orthopaedic research.". J Bone Joint Surg Am 2002,84-A(8):1490–6.PubMed
go back to reference Wedemeyer C, Neuerburg C, et al.: "Polyethylene particle-induced bone resorption in alpha-calcitonin generelated peptide-deficient mice.". J Bone Miner Res 2007,22(7):1011–9. 10.1359/jbmr.070408PubMedCrossRef Wedemeyer C, Neuerburg C, et al.: "Polyethylene particle-induced bone resorption in alpha-calcitonin generelated peptide-deficient mice.". J Bone Miner Res 2007,22(7):1011–9. 10.1359/jbmr.070408PubMedCrossRef
go back to reference Young RL, Korsmeyer SJ: "A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter.". Mol Cell Biol 1993,13(6):3686–97.PubMedCentralPubMed Young RL, Korsmeyer SJ: "A negative regulatory element in the bcl-2 5'-untranslated region inhibits expression from an upstream promoter.". Mol Cell Biol 1993,13(6):3686–97.PubMedCentralPubMed
Metadata
Title
BCL2-938C > A and CALCA-1786T > C polymorphisms in aseptic loosened total hip arthroplasty
Authors
C Wedemeyer
MD Kauther
S Hanenkamp
H Nückel
M Bau
W Siffert
HS Bachmann
Publication date
01-12-2009
Publisher
BioMed Central
Published in
European Journal of Medical Research / Issue 6/2009
Electronic ISSN: 2047-783X
DOI
https://doi.org/10.1186/2047-783X-14-6-250

Other articles of this Issue 6/2009

European Journal of Medical Research 6/2009 Go to the issue